Abstract:IGF2BP3 increased CTCF expression to promote the transcriptional process of NT5DC2, thus accelerating M2 macrophage polarization, which in turn increased cell proliferation, tube formation, and glucose metabolism and inhibited cell apoptosis, ultimately promoting the malignant progression of LUSC. Background Lung squamous cell carcinoma (LUSC) is a type of lung cancer that develops in the squamous cells. It is known to be promoted by the activation of various signaling pathways and the dysregulation of key regulatory molecules. One such molecule, 5′‐nucleotidase domain containing 2 (NT5DC2), has been identified as a critical regulator in various cancers including lung cancer. However, there are no data regarding its role in LUSC. Methods The mRNA expression of insulin‐like growth factor 2 mRNA–binding protein 3 (IGF2BP3), CCCTC‐binding factor (CTCF), and NT5DC2 was analyzed using quantitative real‐time polymerase chain reaction (qRT‐PCR), whereas their protein expression was assessed using a western blotting assay. Cell proliferation was determined using a cell counting kit‐8 (CCK‐8) assay. Cell apoptosis, CD11b expression, and CD206 expression were analyzed using flow cytometry. Tube formation was assessed through a tube formation assay. Glucose consumption, lactate production, and ATP levels were measured using colorimetric methods. The effect of NT5DC2 on the malignant progression of LUSC cells was analyzed using a xenograft mouse model assay. The levels of transforming growth factor‐beta 1 (TGF‐β1) and interleukin‐10 (IL‐10) were detected using enzyme‐linked immunosorbent assays. The associations among IGF2BP3, CTCF and NT5DC2 were identified using dual‐luciferase reporter assay, RNA immunoprecipitation assay and m6A RNA immunoprecipitation assay. Results The expression of NT5DC2 was found to be upregulated in LUSC tissues and cells when compared with normal lung tissues and normal human bronchial epithelial cells. Silencing of NT5DC2 inhibited LUSC cell proliferation, tube formation, glycolysis, M2 macrophage polarization, and tumor formation while inducing cell apoptosis. In addition, CTCF was found to transcriptionally activate NT5DC2 in LUSC cells. IGF2BP3 stabilized the mRNA expression of CTCF through m6A methylation. Further, overexpression of CTCF or NT5DC2 attenuated the effects of IGF2BP3 silencing in both NCI‐520 and SK‐MES‐1 cells. Conclusion The IGF2BP3/CTCF axis–dependent NT5DC2 promotes M2 macrophage polarization, thereby enhancing the malignant progression of LUSC. This study was the first to reveal the role of NT5DC2 in LUSC and the underlying mechanism. The result suggests that targeting the IGF2BP3/CTCF/NT5DC2 axis may have clinical significance in the treatment of LUSC.

CEBPA facilitates LOXL2 and LOXL3 transcription to promote BCL-2 stability and thus enhances the growth and metastasis of lung carcinoma cells in vitro

The Novel KLF4/PLAC8 Signaling Pathway Regulates Lung Cancer Growth.

LCAT1 is an Oncogenic LncRNA by Stabilizing the IGF2BP2-CDC6 Axis

CBX8 Promotes Epithelial-mesenchymal Transition, Migration, and Invasion of Lung Cancer through Wnt/β-catenin Signaling Pathway

LINC00882 , transcriptionally activated by CEBP-β and post-transcriptionally stabilized by METTL14-mediated m 6 A modification, exerts tumorigenesis by promoting PABPC1-mediated stabilization of ELK3 mRNA

LINC00882, Transcriptionally Activated by CEBP-β and Post-Transcriptionally Stabilized by METTL14-mediated M6a Modification, Exerts Tumorigenesis by Promoting PABPC1-mediated Stabilization of ELK3 Mrna

LRRC45 promotes lung cancer proliferation and progression by enhancing c-MYC, slug, MMP2, and MMP9 expression

CCL20 Promotes Lung Adenocarcinoma Progression by Driving Epithelial-Mesenchymal Transition

Identification ofLBX2as a novel causal gene of lung adenocarcinoma

The role of LOXL2 in tumor progression, immune response and cellular senescence: a comprehensive analysis

Loss of LOXL2 promotes uterine hypertrophy and tumor progression by enhancing H3K36ac-dependent gene expression

IGF2BP3/CTCF Axis–Dependent NT5DC2 Promotes M2 Macrophage Polarization to Enhance the Malignant Progression of Lung Squamous Cell Carcinomas

The Interaction of LOXL2 with GATA6 Induces VEGFA Expression and Angiogenesis in Cholangiocarcinoma

LOXL3-promoted hepatocellular carcinoma progression via promotion of Snail1/USP4-mediated epithelial-mesenchymal transition

LOXL1 confers antiapoptosis and promotes gliomagenesis through stabilizing BAG2

A long non‐coding RNA LNBC3 facilitates non‐small cell lung cancer progression by stabilizing BCL6

Advances in lung adenocarcinoma: A novel perspective on prognoses and immune responses of CENPO as an oncogenic superenhancer

PCGF2 Acts as an Oncogenic Driver in Colon Cancer through the Upregulation of CENPE

Lysyl Oxidase Promotes Liver Metastasis of Gastric Cancer Via Facilitating the Reciprocal Interactions Between Tumor Cells and Cancer Associated Fibroblasts.

Interaction between CASP8AP2 and ZEB2-CtBP2 Regulates the Expression of <i>LEF1</i>

Low expression of lysosome-related genes KCNE1, NPC2, and SFTPD promote cancer cell proliferation and tumor associated M2 macrophage polarization in lung adenocarcinoma